Table 4.
Risk factors | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% confidence interval | P value | Hazard ratio | 95% confidence interval | P value | |
Age (> 50) | 0.81 | 0.33–1.98 | 0.64 | 0.78 | 0.29–2.17 | 0.64 |
Sex (male) | 0.84 | 0.34–2.07 | 0.71 | |||
Small BSA (< 1.5 m2) | 1.91 | 0.80–4.54 | 0.15 | |||
Delayed heparinization (> 24 h) | 2.91 | 1.02–8.26 | 0.045 | 2.9 | 0.98–8.56 | 0.053 |
Preoperative small LVDs (< 50 mm) | 2.98 | 1.25–7.12 | 0.014 | 2.36 | 0.76–7.35 | 0.14 |
Preoperative inflammation (WBC > 10,000/mm3) | 1.12 | 0.26–4.79 | 0.88 | |||
Preoperative hypoalbuminemia (< 3.0 g/dl) | 1.68 | 0.49–5.71 | 0.41 | |||
Long operation time (> 300 min) | 3.45 | 1.45–8.22 | 0.0053 | |||
Bridging with extracorporeal VAD | 3.38 | 1.46–7.81 | 0.0044 | 4.27 | 1.43–12.8 | 0.0095 |
HeartMate II implantation | 4.1 | 0.54–30.7 | 0.17 | 3.74 | 0.48–29.3 | 0.21 |
LVDs left ventricular end-systolic diameter, WBC white blood cell, VAD ventricular assist device, BSA body surface area